-
Notifications
You must be signed in to change notification settings - Fork 3
Pyrazine Side Chain Modifications Reversed Amides
Compounds were made with the amide "reversed", i.e. the N atom attached to the pyrazine ring. The acetamide (OSM-W-6) demonstrated marginal activity, but incurred an approximate order of magnitude loss in potency as compared to amide MMV669543. The one carbon homolog OSM-W-7 was found to be inactive for both lines evaluated (Dd2 and 3D7). OSM-S-272 (MMV639565) (resynthesised) was used as a positive control in the assay. OSM-W-9 was synthesized to provide a compound that could serve as a bridge in the SAR between analogs containing the para-Cyano moiety versus the para-Difluoromethoxy.
Additionally, when OSM-W-7 was evaluated in the aldehyde oxidase assay, the compound displayed moderate clearance, meaning the amide reversal did not prevent the molecule being a substrate for that enzyme (which was the original intent). Furthermore, OSM-W-7 also showed rapid clearance in a generalized HLM stability assay.
Aims, Concerns and Current Interest in Series 4
Modification of Core Triazolopyrazine
Modification of Pyrazine Substitution Pattern
Modification of the Triazole Substitution
Pyrazine Side Chain Modifications - Ethers
Pyrazine Side Chain Modifications - Amides
Pyrazine Side Chain Modifications - Reversed Amides
Pyrazine Side Chain Modifications - Others
Biological Data Currently not Incorporated into the Main Wiki Sections
Mechanism of Action: Possible PfATP4 Activity Deduced from Parasite Ion Regulation Assays
Synthesis of the Ether-Linked Series
Synthesis of the Amide-Linked Series
Synthesis of the Reverse Amide- Linked Series
Synthesis of Benzylic Functionalised Ether-Linked Series
Alternative Routes to the Triazolopyrazine Core
Triazolopyrazine telesubstitution
Chirality/Stereogenic Centres in This Series
Other Sources of Compounds Relevant to this Series
Desirable Compounds Not Yet Synthesised